Results of a key trial of an Eisai and Biogen Alzheimer’s drug have reignited hopes that targeting amyloid beta helps arrest disease progression.
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week…
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
Colorado lawmakers are abandoning a bill that would have required a new state board — chartered with setting caps for the cost of medicines — to…
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal…
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s…
The number of ongoing and active drug shortages in the U.S. stood at 323 during the fourth quarter of last year — the highest figure…
The European Parliament voted to adopt legislation that is supposed to transform the way medicines are brought to market and accessed across much of Europe.
The U.S. Department of Justice filed a lawsuit accusing Regeneron Pharmaceuticals of manipulating Medicare pricing by inflating the average sales price
